The listing window has narrowed
2025 brought 13 listings on the Main Market and 24 on Nomu [1]. The first eight months of 2026 saw three across both markets [2]. Of the 37 companies that offered shares in 2025, only seven were trading above their offer price at the end of August 2026, and 29 were below it [3].
Investors who lost money on the 2025 group will look harder at the next one. A company preparing to list now needs a growth story that survives close questioning.
Forecasts now sit in the prospectus
The CMA's new IPO requirements make forward-looking disclosure mandatory [4]. Expectations that once lived in analyst presentations now have to be in the offering document. A forecast in a CMA document needs a market case behind it that the directors and advisers are comfortable standing behind.
All categories of foreign investor have been able to buy Main Market shares directly since February 2026 [5]. Many of them expect independent market evidence as a matter of course.
Where we fit
Before a pre-IPO round
Buy-side work for investors coming in a year or two before the listing, testing the equity story they are paying for.
Nomu to the Main Market
A Main Market listing needs three years of financial statements, against one year for Nomu [5], and brings a larger, more demanding investor base. We check that the growth story still holds for them.
Before drafting starts
Sizing the market, testing competitor claims and the assumptions behind the forecast, so the prospectus and the investor presentation are built on the same evidence.
What we do not do
We do not hold a CMA licence and do not act as financial adviser, underwriter or arranger on an offering. Financial due diligence is done by the reporting accountant and legal due diligence by the legal adviser [6]. We work alongside them on the market evidence.
Questions we're asked
How early should we start?
Before prospectus drafting begins, so the market section and the forecast are built on the same evidence.
Can you work for a pre-IPO investor rather than the company?
Yes. Buy-side work for a pre-IPO investor is one of the most common uses.
Do you prepare the prospectus?
No. We supply market evidence to the company and its advisers, who prepare the offering document.
Sources
- Argaam, 2025 IPOs: 13 listings on TASI, 24 on Nomu
- Argaam, New Saudi IPO rules to boost market appeal or raise listing costs?
- Argaam, Saudi Arabia logs fewest IPOs in first 8 months of 2026
- Gibson Dunn, Saudi CMA issues new requirements for IPOs, November 2026
- Baker McKenzie, Saudi Stock Exchange: quick summary
- Baker McKenzie, Saudi Stock Exchange: listing documentation and process